6:09 PM
 | 
Dec 13, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Hookipa raises €50M series C

Hookipa Biotech AG (Vienna, Austria) raised €50 million ($59.4 million) in a series C round led by an undisclosed U.S. public investment fund specializing in life sciences. Fellow new investors HBM Partners, Hillhouse Capital, Sirona Capital and Gilead Sciences Inc. (NASDAQ:GILD) also participated, as did existing investors Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda...

Read the full 263 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >